Califf, R.M. Biomarker definitions and their applications. Exp. Biol. Med. (Maywood), 2018 Feb;243(3), 213-221.
[http://dx.doi.org/10.1177/1535370217750088] [PMID: 29405771] [PMCID: PMC5813875]

Nikanjam, M.; Kato, S.; Kurzrock, R. Liquid biopsy: current technology and clinical applications. J. Hematol. Oncol., 2022 Sep 12;15(1), 131.
[http://dx.doi.org/10.1186/s13045-022-01351-y] [PMID: 36096847] [PMCID: PMC9465933]

Yu, S.C.Y.; Choy, L.Y.L.; Lo, Y.M.D. ‘Longing’ for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing. Mol. Diagn. Ther., 2023 Sep;27(5), 563-571. Epub 2023 Jul 20
[http://dx.doi.org/10.1007/s40291-023-00661-2] [PMID: 37474843] [PMCID: PMC10435595]

Bianchi, D.W.; Chiu, R.W.K. Sequencing of Circulating Cell-free DNA during Pregnancy. N. Engl. J. Med., 2018 Aug 2;379(5), 464-473.
[http://dx.doi.org/10.1056/NEJMra1705345] [PMID: 30067923] [PMCID: PMC10123508]

Zhang, J.; Wu, Y.; Chen, S. Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies. Nat. Med., 2024, 30, 470-479.
[http://dx.doi.org/10.1038/s41591-023-02774-x]

Lo, Y.M.D.; Han, D.S.C.; Jiang, P.; Chiu, R.W.K. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science, 2021 Apr 9;372(6538), eaaw3616.
[http://dx.doi.org/10.1126/science.aaw3616] [PMID: 33833097]

Mattox, AK; Bettegowda, C; Zhou, S; Papadopoulos, N; Kinzler, KW; Vogelstein, B Applications of liquid biopsies for cancer. Sci Transl Med., 2019 Aug 28, 11(507), eaay1984.
[http://dx.doi.org/10.1126/scitranslmed.aay1984] [PMID: 31462507]

Ding, S.C.; Lo, Y.M.D. Cell-Free DNA Fragmentomics in Liquid Biopsy. Diagnostics (Basel), 2022 Apr 13;12(4), 978.
[http://dx.doi.org/10.3390/diagnostics12040978] [PMID: 35454026] [PMCID: PMC9027801]

Jiang, P.; Lo, Y.M.D. Enhanced cancer detection from cell-free DNA. Nat. Biotechnol., 2022 Apr;40(4), 473-474.
[http://dx.doi.org/10.1038/s41587-021-01207-9] [PMID: 35361997]

Bulun, S.E.; Yildiz, S.; Adli, M.; Wei, J.J. Adenomyosis pathogenesis: insights from next-generation sequencing. Hum. Reprod. Update, 2021 Oct 18;27(6), 1086-1097.
[http://dx.doi.org/10.1093/humupd/dmab017] [PMID: 34131719] [PMCID: PMC8543024]

Chiorean, D.M.; Mitranovici, M.I.; Toru, H.S.; Cotoi, T.C.; Tomuț, A.N.; Turdean, S.G.; Cotoi, O.S. New Insights into Genetics of Endometriosis-A Comprehensive Literature Review. Diagnostics (Basel), 2023 Jul 4;13(13), 2265.
[http://dx.doi.org/10.3390/diagnostics13132265] [PMID: 37443659] [PMCID: PMC10340419]

Devarbhavi, P.; Telang, L.; Vastrad, B.; Tengli, A.; Vastrad, C.; Kotturshetti, I. Identification of key pathways and genes in polycystic ovary syndrome viaintegrated bioinformatics analysis and prediction of small therapeutic molecules. Reprod. Biol. Endocrinol., 2021 Feb 23;19(1), 31.
[http://dx.doi.org/10.1186/s12958-021-00706-3] [PMID: 33622336] [PMCID: PMC7901211]

Gasiorek, M.; Hsieh, M.H.; Forster, C.S. Utility of DNA Next-Generation Sequencing and Expanded Quantitative Urine Culture in Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms. J. Clin. Microbiol., 2019 Dec 23;58(1), e00204-e00219.
[http://dx.doi.org/10.1128/JCM.00204-19] [PMID: 31619534] [PMCID: PMC6935904]

Sun, B.; Yeh, J. Calcium Oscillatory Patterns and Oocyte Activation During Fertilization: a Possible Mechanism for Total Fertilization Failure (TFF) in Human in vitroFertilization? Reprod. Sci., 2021 Mar;28(3), 639-648. Epub 2020 Aug 19.
[http://dx.doi.org/10.1007/s43032-020-00293-5] [PMID: 32813196]

Sun, B.; Yeh, J. Identifying fertilization-ready metaphase II stage oocytes beyond the microscope: a proposed molecular path forward, F&S Reviews, Volume 2, Issue 4, 2021, Pages 302-316, ISSN 2666-5719,
[http://dx.doi.org/10.1016/j.xfnr.2021.09.001]

Sun, B.; Yeh, J. Onco-fertility and personalized testing for potential for loss of ovarian reserve in patients undergoing chemotherapy: proposed next steps for development of genetic testing to predict changes in ovarian reserve. Fertil. Res. and Pract., 2021, 7, 13.
[http://dx.doi.org/10.1186/s40738-021-00105-7]

Sun, B.; Yeh, J. Non-Invasive and Mechanism-Based Molecular Assessment of Endometrial Receptivity During the Window of Implantation: Current Concepts and Future Prospective Testing Directions. Front Reprod Health., 2022 May 4;4, 863173.
[http://dx.doi.org/10.3389/frph.2022.863173] [PMID: 36303672] [PMCID: PMC9580756]

Zhu, J.W.; Charkhchi, P.; Akbari, M.R. Potential clinical utility of liquid biopsies in ovarian cancer. Mol. Cancer, 2022 May 11;21(1), 114.
[http://dx.doi.org/10.1186/s12943-022-01588-8] [PMID: 35545786] [PMCID: PMC9092780]

Karimi, F.; Azadbakht, O.; Veisi, A. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis. Med. Oncol., 2023, 40, 265.
[http://dx.doi.org/10.1007/s12032-023-02128-0]

Ashley, C.W.; Selenica, P.; Patel, J. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. Clin. Cancer Res., 2023 Jan 17;29(2), 410-421.
[http://dx.doi.org/10.1158/1078-0432.CCR-22-1134] [PMID: 36007103] [PMCID: PMC9852004]

Thangarajah, F.; Busshoff, J.; Salamon, J. Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer. J. Cancer Res. Clin. Oncol., 2023 Nov;149(14), 12597-12604. Epub 2023 Jul 14.
[http://dx.doi.org/10.1007/s00432-023-05077-3] [PMID: 37452202] [PMCID: PMC10587338]